Toggle navigation
About
Approach
Team
Companies
News Room
Contact
Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters
Press Release
Evotec and venture capital consortium form "Breakpoint Therapeutics GmbH"
Press Release
Aura Biosciences Completes $40 Million Series D Financing
Press Release
Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors
Press Release
Celgene to acquire Impact Biomedicines, adding Fedratinib to its pipeline of novel therapies for hematologic malignancies
Press Release
